Institute of Medicine (U.S.). Board on Population Health and Public Health Practice, Institute of Medicine (U.S.). Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, ebrary, Inc, & Wizemann, T. M. (2011). Public health effectiveness of the FDA 510(k) clearance process: Balancing patient safety and innovation : workshop report. National Academies Press.
Kopierad till urklipp
Kopiering till urklipp misslyckades
Chicago-referens (17:e uppl.)
Institute of Medicine (U.S.). Board on Population Health and Public Health Practice, Institute of Medicine (U.S.). Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Inc ebrary, och Theresa M. Wizemann. Public Health Effectiveness of the FDA 510(k) Clearance Process: Balancing Patient Safety and Innovation : Workshop Report. Washington, D.C.: National Academies Press, 2011.
Kopierad till urklipp
Kopiering till urklipp misslyckades
MLA-referens (9:e uppl.)
Institute of Medicine (U.S.). Board on Population Health and Public Health Practice, et al. Public Health Effectiveness of the FDA 510(k) Clearance Process: Balancing Patient Safety and Innovation : Workshop Report. National Academies Press, 2011.
Kopierad till urklipp
Kopiering till urklipp misslyckades
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.